Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.

MLA

Martín Monreal, María Teresa, et al. “Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.” Frontiers in Immunology, vol. 12, Oct. 2021, p. 716250. EBSCOhost, https://doi.org/10.3389/fimmu.2021.716250.

APA

Martín Monreal, M. T., Rebak, A. S., Massarenti, L., Mondal, S., Šenolt, L., Ødum, N., Nielsen, M. L., Thompson, P. R., Nielsen, C. H., & Damgaard, D. (2021). Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4. Frontiers in Immunology, 12, 716250. https://doi.org/10.3389/fimmu.2021.716250

Chicago

Martín Monreal, María Teresa, Alexandra Stripp Rebak, Laura Massarenti, Santanu Mondal, Ladislav Šenolt, Niels Ødum, Michael L Nielsen, Paul R Thompson, Claus H Nielsen, and Dres Damgaard. 2021. “Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.” Frontiers in Immunology 12 (October): 716250. doi:10.3389/fimmu.2021.716250.